Loading clinical trials...
Loading clinical trials...
This is a first-in-human (FIH) study designed to assess the safety, tolerability, and pharmacokinetic (PK) profile of IMC-S118AI in single-ascending dose (SAD) and multiple-ascending dose (MAD) regime...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Immunocore Ltd
NCT07224321 · Type 1 Diabetes Mellitus
NCT07395050 · Stage 3 Type 1 Diabetes
NCT07360080 · Type 1 Diabetes
NCT07457580 · Type 1 Diabetes
NCT06815081 · Type 1 Diabetes (T1D), Type 2 Diabetes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions